# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875045-19-000017
Filing Date
2019-04-24
Accepted
2019-04-24 16:46:37
Documents
121
Period of Report
2019-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | biib-2019331x10q.htm | 10-Q | 2020423
2 | EXHIBIT 10.1 | biib-2019331xex101.htm | EX-10.1 | 33240
3 | EXHIBIT 31.1 | biib-2019331xex311.htm | EX-31.1 | 14189
4 | EXHIBIT 31.2 | biib-2019331xex312.htm | EX-31.2 | 14943
5 | EXHIBIT 32.1 | biib-2019331xex321.htm | EX-32.1 | 10784
12 |  | amortofacquireintanassets.jpg | GRAPHIC | 17727
13 |  | anticd20revenues.jpg | GRAPHIC | 35899
14 |  | biogenlogostandardrgbr.jpg | GRAPHIC | 95992
15 |  | biosimilars.jpg | GRAPHIC | 25923
16 |  | collabprofitshare.jpg | GRAPHIC | 16795
17 |  | costofsales.jpg | GRAPHIC | 24984
18 |  | equityinlossofinvestee.jpg | GRAPHIC | 14745
19 |  | financialhighlights.jpg | GRAPHIC | 36973
20 |  | fvonremeasurementofcc.jpg | GRAPHIC | 17315
21 |  | incometaxprovision.jpg | GRAPHIC | 25253
22 |  | interferon.jpg | GRAPHIC | 27402
23 |  | lossonheldforsale.jpg | GRAPHIC | 15391
24 |  | oie.jpg | GRAPHIC | 17546
25 |  | otherrevenue.jpg | GRAPHIC | 23725
26 |  | rdandpercentofrevenue.jpg | GRAPHIC | 31043
27 |  | researchanddev.jpg | GRAPHIC | 50270
28 |  | reservesfordisandallow.jpg | GRAPHIC | 28274
29 |  | sganda.jpg | GRAPHIC | 17699
30 |  | spinraza.jpg | GRAPHIC | 26258
31 |  | tecfidera.jpg | GRAPHIC | 28903
32 |  | tysabri.jpg | GRAPHIC | 27301
| Complete submission text file | 0000875045-19-000017.txt |  | 12259928

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE DOCUMENT | biib-20190331.xml | EX-101.INS | 2800199
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20190331.xsd | EX-101.SCH | 71062
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | biib-20190331_cal.xml | EX-101.CAL | 127996
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | biib-20190331_def.xml | EX-101.DEF | 405509
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20190331_lab.xml | EX-101.LAB | 980399
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20190331_pre.xml | EX-101.PRE | 602258

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 19764364
SIC: 2836 Biological Products, (No Diagnostic Substances)